from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2927c/-

LFCtreatmentdescriptionclass of inhibitor

1.327

Amikacinug/mL Amikacintranslation

0.753

Cap5-10ug/mL Capreomycintranslation

0.381

Rox10-50 ug/mL Roxithromycintranslation

-0.517

SM2-5 ug/mL Streptomycintranslation

0.769

Tet5-10 ug/mL Tetracyclinetranslation

-0.766

Rif0.2-5ug/mL Rifampicintranscription

-1.016

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.627

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.631

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.140

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.926

Clofazimine10-13 ug/mL Clofaziminerespiration

0.078

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.476

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.019

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.574

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.010

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.998

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.703

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.923

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.555

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.161

KCN5-20 ug/mL Potassium cyaniderespiration

0.394

NaN30.2-2 mM Sodium aziderespiration

0.021

Nigericin50 uM Nigericinrespiration

0.698

TRC10-150 ug/mL Triclosanrespiration

0.275

TRZ10-25 ug/mL Thioridazinerespiration

-0.644

Valinomycin0.5-10 uM Valinomycinrespiration

0.540

ZnSO42 mM ZnSO4respiration

-0.662

menadione6-10 ug/mL Menadionerespiration

-1.510

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.218

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.908

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.045

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.851

NRP_1Non-replicating persistence stage 1dosRassociated

0.699

Amp0.2mg/mL AmpicillincellWall

0.611

Cephalexin20-100 ug/mL CephalexincellWall

-0.284

Cerulenin0.32-5 ug/mL CerulenincellWall

0.189

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.003

EMB10-20 ug/mL EthambutolcellWall

1.036

Eta12-40 ug/mL EthionamidecellWall

0.865

INH0.2-0.4 ug/mL IsoniazidcellWall

0.082

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.750

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.612

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.691

BZA0.12 mg/mL BenzamidearomaticAmides

0.725

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.587

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.447

H2O24 mM hydrogen peroxideDNAdamaging

0.058

Levo10 ug/mL LevofloxacinDNAdamaging

-0.968

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.308

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.572

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.468

UVUV-irradiationDNAdamaging

-2.015

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.902

Antimycin12.5-50 ug/mL Antimycin A?

0.287

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.049

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.062

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.993

PA8240.2-2 ug/mL PA-824?

0.828

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.027

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.157

Verapamil50 uM Verapamil?

-0.197

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.181

methoxatin10-20 ug/mL Methoxatin?